CAPRICOR THERAPEUTICS INC. - COMMON STOCK
18.62
22-November-24 15:44:58
15 minutes delayed
Stocks
+0.83
+4.67%
Today's range
17.51 - 18.88
ISIN
N/A
Source
NASDAQ
-
11 Mar 2022 07:00:00 By Nasdaq GlobeNewswire
-
10 Mar 2022 15:01:00 By Nasdaq GlobeNewswire
-
03 Mar 2022 08:15:00 By Nasdaq GlobeNewswire
-
Capricor Therapeutics Names Dr. Daniel Paulson as Vice President of Clinical Development
02 Mar 2022 08:00:01 By Nasdaq GlobeNewswire
-
Capricor Therapeutics Announces Key Updates on its Vaccine and Therapeutic Programs for COVID-19
13 Dec 2021 08:15:00 By Nasdaq GlobeNewswire
-
Capricor’s CEO Dr. Linda Marbán to Serve as Keynote Speaker at TriLink Annual mRNA Day
12 Nov 2021 08:15:00 By Nasdaq GlobeNewswire
-
Capricor Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update
09 Nov 2021 15:05:02 By Nasdaq GlobeNewswire
-
02 Nov 2021 15:05:01 By Nasdaq GlobeNewswire
-
24 Sep 2021 06:00:00 By Nasdaq GlobeNewswire
-
Capricor Therapeutics to Present at the Upcoming Investor and Industry Healthcare Conferences
22 Sep 2021 15:05:00 By Nasdaq GlobeNewswire
-
Capricor Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
07 Sep 2021 08:00:00 By Nasdaq GlobeNewswire
-
02 Sep 2021 07:30:00 By Nasdaq GlobeNewswire
-
Capricor Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update
12 Aug 2021 15:01:00 By Nasdaq GlobeNewswire
-
05 Aug 2021 08:00:00 By Nasdaq GlobeNewswire
-
04 Aug 2021 07:00:01 By Nasdaq GlobeNewswire
-
Capricor Therapeutics Announces the Appointment of Karimah Es Sabar to its Board of Directors
27 Jul 2021 07:00:04 By Nasdaq GlobeNewswire
-
17 Jun 2021 08:00:00 By Nasdaq GlobeNewswire
-
Capricor Therapeutics to Participate in BIO Digital 2021 Conference
10 Jun 2021 08:15:00 By Nasdaq GlobeNewswire
-
18 May 2021 07:30:00 By Nasdaq GlobeNewswire